Randy V. Heysek

724 total citations
20 papers, 569 citations indexed

About

Randy V. Heysek is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Randy V. Heysek has authored 20 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Immunology. Recurrent topics in Randy V. Heysek's work include Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (6 papers) and Immunotherapy and Immune Responses (4 papers). Randy V. Heysek is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (6 papers) and Immunotherapy and Immune Responses (4 papers). Randy V. Heysek collaborates with scholars based in United States. Randy V. Heysek's co-authors include Paul B. Jacobsen, Julio M. Pow‐Sang, Babu Zachariah, Clement K. Gwede, Alan Cantor, Mayer Fishman, John D. Seigne, Heather Jim, Mohamed Helal and Matthew C. Biagioli and has published in prestigious journals such as Cancer, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Randy V. Heysek

20 papers receiving 560 citations

Peers

Countries citing papers authored by Randy V. Heysek

Since Specialization

Citations

This map shows the geographic impact of Randy V. Heysek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy V. Heysek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy V. Heysek more than expected).

Fields of papers citing papers by Randy V. Heysek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy V. Heysek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy V. Heysek. The network helps show where Randy V. Heysek may publish in the future.

Co-authorship network of co-authors of Randy V. Heysek

This figure shows the co-authorship network connecting the top 25 collaborators of Randy V. Heysek. A scholar is included among the top collaborators of Randy V. Heysek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy V. Heysek. Randy V. Heysek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Freedom from Recurrence across Age in Non-Melanoma Skin Cancer Treated with Image-Guided Superficial Radiation Therapy 2024 ·Geriatrics ·Aaron S. Farberg, Randy V. Heysek, Robert S. Haber, (unknown), (unknown), Xinge Ji, (unknown)	1
2	Image-Guided Superficial Radiation Therapy for Basal and Squamous Cell Carcinomas Produces Excellent Freedom from Recurrence Independent of Risk Factors 2024 ·Journal of Clinical Medicine ·(unknown), Randy V. Heysek, (unknown), (unknown), (unknown), Kathryn O’Reilly, Steven E. Finkelstein, Aaron S. Farberg	1
3	Health-related quality-of-life changes due to high-dose-rate brachytherapy, low-dose-rate brachytherapy, or intensity-modulated radiation therapy for prostate cancer 2015 ·Brachytherapy ·Tobin J. Strom, (unknown), Nicholas Figura, (unknown), (unknown), Eric A. Mellon, Daniel C. Fernandez, Amarjit Saini, Dylan Hunt, Randy V. Heysek, Richard B. Wilder	11
4	Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison 2015 ·Supportive Care in Cancer ·Brian D. Gonzalez, Heather Jim, Brent J. Small, Steven K. Sutton, Mayer Fishman, Babu Zachariah, Randy V. Heysek, Paul B. Jacobsen	40
5	Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer 2014 ·International Journal of Clinical Oncology ·A.O. Naghavi, Tobin J. Strom, (unknown), (unknown), Nicholas Figura, (unknown), Binglin Yue, Jongphil Kim, Matthew C. Biagioli, Daniel C. Fernandez, Randy V. Heysek, Richard B. Wilder	10
6	Informed decision making among first-degree relatives of prostate cancer survivors: A pilot randomized trial 2014 ·Contemporary Clinical Trials ·Stacy N. Davis, Steven K. Sutton, Susan T. Vadaparampil, Cathy D. Meade, Brian M. Rivers, (unknown), Javier F. Torres–Roca, Randy V. Heysek, Philippe E. Spiess, Julio M. Pow‐Sang, Paul B. Jacobsen, Clement K. Gwede	3
7	Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison 2014 ·Psycho-Oncology ·Morgan Lee, Heather Jim, Mayer Fishman, Babu Zachariah, Randy V. Heysek, Matthew C. Biagioli, Paul B. Jacobsen	64
8	Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives 2014 ·American Journal of Health Promotion ·Clement K. Gwede, Stacy N. Davis, (unknown), (unknown), Susan T. Vadaparampil, Cathy D. Meade, Brian M. Rivers, Daohai Yu, Javier F. Torres–Roca, Randy V. Heysek, Philippe E. Spiess, Julio M. Pow‐Sang, Paul B. Jacobsen	9
9	External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer 2014 ·International braz j urol ·Tobin J. Strom, (unknown), (unknown), (unknown), Nicholas Figura, (unknown), Matthew C. Biagioli, Daniel C. Fernandez, Randy V. Heysek, Richard B. Wilder	8
10	Serial Assessment of Lymphocytes and Apoptosis in the Prostate During Coordinated Intraprostatic Dendritic Cell Injection and Radiotherapy 2012 ·Immunotherapy ·Steven E. Finkelstein, Francisco R. Rodriguez, Mary Dunn, (unknown), (unknown), William E. Janssen, Loveleen Kang, (unknown), John D. Seigne, Julio M. Pow‐Sang, Javier F. Torres–Roca, Randy V. Heysek, (unknown), Ravi Shankar, Jacob G. Scott, Scott Antonia, Dmitry I. Gabrilovich, Mayer Fishman	34
11	Combination of External Beam Radiotherapy (EBRT) With Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Steven E. Finkelstein, Cristina Iclozan, Marilyn M. Bui, Matthew J. Cotter, Rupal Ramakrishnan, (unknown), David Noyes, David Cheong, Ricardo González, Randy V. Heysek, Claudia G. Berman, Brianna Lenox, William E. Janssen, Jonathan S. Zager, Vernon K. Sondak, G. Douglas Letson, Scott Antonia, Dmitry I. Gabrilovich	101
12	Serum IL-R1a and IP-10 Cytokine/chemokine Profiling Differences in Immune Responders and Non-responders to Combination Radiation / Immunotherapy for Soft Tissue Sarcoma 2010 ·International Journal of Radiation OncologyBiologyPhysics ·David Noyes, Brianna Lenox, (unknown), David Cheong, Ricardo J. Gonzalez, Randy V. Heysek, Jonathan S. Zager, Scott Antonia, Dmitry I. Gabrilovich, (unknown)	2
13	At the Confluence of Radiation Therapy and Immunotherapy: External Beam Radiation (EBRT) with Intratumoral Injection of Dendritic Cells as Neoadjuvant Treatment of High-risk Soft Tissue Sarcoma Patients 2009 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Dmitry I. Gabrilovich, Marilyn M. Bui, Matthew J. Cotter, David Cheong, Ricardo J. Gonzalez, Randy V. Heysek, Vernon K. Sondak, G. Douglas Letson, Scott Antonia	3
14	Association Between Polymorphisms in HSD3B1 and UGT2B17 and Prostate Cancer Risk 2007 ·Urology ·Jong Y. Park, (unknown), Thomas A. Sellers, Yifan Huang, (unknown), (unknown), Ravi Shankar, Babu Zachariah, Randy V. Heysek, Julio M. Pow‐Sang	37
15	Modern Brachytherapy for Treatment of Prostate Cancer 2007 ·Cancer Control ·Randy V. Heysek	23
16	A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy 2006 ·Brachytherapy ·Randy V. Heysek, Clement K. Gwede, Javier F. Torres–Roca, Alan Cantor, (unknown), Amarjit Saini, (unknown)	28
17	Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: A review of the H. Lee Moffitt Cancer Center experience 2006 ·Urologic Oncology Seminars and Original Investigations ·Javier F. Torres–Roca, Alan Cantor, (unknown), (unknown), Jay L. Friedland, John D. Seigne, Randy V. Heysek, Julio M. Pow‐Sang	4
18	Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men 2006 ·Cancer Epidemiology Biomarkers & Prevention ·Jong-Hak Park, Lan Chen, (unknown), Thomas A. Sellers, (unknown), Ji‐Hyun Lee, (unknown), Nicholas P. Lang, Fred F. Kadlubar, Christine B. Ambrosone, Babu Zachariah, Randy V. Heysek, Stephen G. Patterson, Julio M. Pow‐Sang	81
19	Treatment decision‐making strategies and influences in patients with localized prostate carcinoma 2005 ·Cancer ·Clement K. Gwede, Julio M. Pow‐Sang, John D. Seigne, Randy V. Heysek, Mohamed Helal, (unknown), Alan Cantor, Paul B. Jacobsen	96
20	Carcinoma of the Male Urethra 1985 ·The Journal of Urology ·Randy V. Heysek, James T. Parsons, David M. Drylie, Rodney R. Million	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact